BowLeven Plc
12 October 2005
12 October 2005
BowLeven Plc
Result of Extraordinary General Meeting
BowLeven Plc ('the Company') announces that following the passing of all the
resolutions put to shareholders at its Extraordinary General Meeting held today,
Wednesday 12 October 2005, the placing of 8,500,000 new ordinary shares of 10p
each ('New Ordinary Shares') at a price of 650p to raise £55.25 million before
expenses has been completed, subject only to admission of the New Ordinary
Shares to trading on AIM. Application has been made to the London Stock
Exchange Plc for the New Ordinary Shares to be admitted to AIM. Dealings are
expected to commence in the New Ordinary Shares on AIM on 18 October 2005.
For further information contact:
Terry Heneaghan, Executive Chairman, BowLeven Plc 0131 260 5100
Adam Westcott, Noble & Company Limited 0131 225 9677
Neil Bennett, Maitland 020 7379 5151
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.